Publications

5891 Results

21q22-balanced chromosome aberrations in therapy-related hematopoietic disorders: report from an international workshop

Authors
ML Slovak;V Bedell;L Popplewell;DA Arber;C Schoch;R Slater
Journal / Conference
Genes Chromosomes & Cancer 33:379-394
Year
2002
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9007

Phase II trial of recombinant human interleukin-4 in patients with advanced renal cell carcinoma: a Southwest Oncology Group study

Authors
RP Whitehead;D Lew;RC Flanigan;GR Weiss;V Roy;LM Glode;SR Dakhil;ED Crawford
Journal / Conference
Journal of Immunotherapy 25(4):352-358
Year
2002
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9230

Adjuvant chemohormonal therapy for primary breast cancer should be sequential instead of concurrent: initial results from Intergroup trial 0100 (SWOG-8814).

Authors
KS Albain;SJ Green;PM Ravdin;CD Cobau;EG Levine;JN Ingle;KI Pritchard;DJ Schneider;MD Abeloff;L Norton;IC Henderson;D Lew;RB Livingston;S Martino;CK Osborne
Journal / Conference
Proc of the American Society of Clinical Oncology 21:37a(#143)
Year
2002
Research Committee(s)
Breast
Study Number(s)
SWOG-8814

Cytogenetic and flow cytometric results in advanced renal cell carcinoma: a Southwest Oncology Group study

Authors
RP Whitehead;C Tangen;SR Wolman;RC Flanigan;TV Shankey;ML Slovak;ED Crawford
Journal / Conference
Proc of the American Society of Clinical Oncology 21:147b(#2400)
Year
2002
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9023

HLA-A2 and/or HLA-C3 expression defines a subset of T3N0 melanoma patients with improved overall survival from melacine vaccine: an updated analysis of SWOG 9035.

Authors
JA Sosman;JM Unger;PY Liu;R Kempf;L Flaherty;J Thompson;VK Sondak
Journal / Conference
Proc of the American Society of Clinical Oncology 21:340a(#1359)
Year
2002
Research Committee(s)
Melanoma
Study Number(s)
SWOG-9035

Phase III comparison of adjuvant high-dose doxorubicin plus cyclophosphamide (AC) versus sequential doxorubicin followed by chyclophosphamide (A->C) in breast cancer patients with 0-3 positive nodes (Intergroup 0137)

Authors
CM Haskell;SJ Green;GW Sledge Jr;CL Shapiro;JN Ingle;D Lew;S Martino;R Livingston;CK Osborne
Journal / Conference
Proc of the American Society of Clinical Oncology 21:36a(#142)
Year
2002
Research Committee(s)
Breast
Study Number(s)
SWOG-9313

Induction chemotherapy followed by chemoradiation for organ preservation in patients (pts) with advanced resectable cancer of the base of tongue (BOT) and hypopharynx (HP): a Southwest Oncology Group trial.

Authors
S Urba;J Moon;M LeBlanc;J Forman;D Adelstein;P Giri;E Hanna;J Ensley;D Schuller
Journal / Conference
Proc of the American Society of Clinical Oncology 21:230a(#919)
Year
2002
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-9451

Excellent 2-year survival in women with optimally-debulked ovarian cancer treated with intraperitoneal and intravenous chemotherapy: a SWOG-ECOG-NCIC study (S9619)

Authors
ML Rothenberg;PY Liu;S Wilczynski;PS Braly;S Wadler;G Stuart;EV Hannigan;AJ Bonebrake;DS Alberts;M Markman
Journal / Conference
Proc of the American Society of Clinical Oncology 21:203a(#809)
Year
2002
Research Committee(s)
Gynecologic
Study Number(s)
S9619

Anti-androgen withdrawal in prostate cancer: results from SWOG 9426

Authors
AO Sartor;C Tangen;M Hussain;M Eisenberger;ED Crawford
Journal / Conference
Proc of the American Society of Clinical Oncology 21:197a(#785)
Year
2002
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9426

Continuous infusion (CI) 5 fluorouracil (5FU), leucovorin (LV), mitomycin C (mito C) and dipyridamole (D) in patients with locally advanced unresectable pancreatic adenocarcinoma-a phase II trial of the Southwest Oncology Group

Authors
WH Isacoff;J Benedetti;JS Macdonald;JL Abbruzzese
Journal / Conference
Proc of the American Society of Clinical Oncology 21:137a(#544)
Year
2002
Research Committee(s)
Gastrointestinal
Study Number(s)
S9700